Wockhardt shareholding pattern

·Pharma & HealthChart ›

Who owns itSep 2026 quarter

Promoters49.32%+0.24 pts
Foreign investors (FII)7.02%−0.20 pts
Domestic institutions (DII)9.00%−0.24 pts
of which mutual funds5.99%−0.80 pts
of which insurance companies1.86%
Public34.64%

Per cent of all shares; change on the Jun 2026 quarter, in percentage points. As filed with the exchanges.

Open the chart

From the company's filings with NSE and BSE (Ind-AS), consolidated. For information only, not investment advice.

WOCKPHARMA₹1,922.90

Wockhardt Ltd.

· Pharma & Health
₹ CrorePeersBIOCONSYNGENEASTERDMGLANDPPLPHARMACOHANCELALPATHLABNATCOPHARMMcap ₹31,151 Cr
Holding % of Total Shares
12 Months Ending
Q1 FY25
30/06/2024
Q2 FY25
30/09/2024
Q3 FY25
31/12/2024
Q4 FY25
31/03/2025
Q1 FY26
30/06/2025
Q2 FY26
30/09/2025
Q3 FY26
31/12/2025
Q4 FY26
31/03/2026
Q1 FY27
30/06/2026
Q2 FY27
30/09/2026
Promoter & Group51.9951.9949.0949.0949.0949.0849.0849.0849.0849.32
FII / FPI5.936.706.546.817.297.106.997.097.227.02
DII4.455.099.8210.5911.0111.0110.5510.969.249.00
Mutual Funds2.912.957.137.568.027.897.768.126.795.99
Latest: 2026-09-30 · 64 quarters of history · click a row to chart it.
« ‹ › »Latest: FY26 · ConsolidatedFA Financial Analysis · alphave
Data & compliance. Descriptive financial information from official NSE/BSE filings — for information and education only, not investment advice, a recommendation, or a valuation. Standalone = parent entity; consolidated includes subsidiaries. Historical multiples pair each fiscal year's filed figures with that FY-end market close; the Current column uses the last close with the latest filed annuals. Figures are cross-verified via accounting identities and NSE×BSE agreement — XBRL cross-verified ✓ 95%.